首页 正文

Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014)

{{output}}
Introduction: Cell cycle deregulation is a common characteristic of cancer cells. Progression through the cell cycle is controlled by enzymes known as cyclin-dependent kinases (CDKs), whose activity can be upregulated by a wide r... ...